Pacific Gross Profit from 2010 to 2025

PACB Stock

USD 1.30 0.04 3.17%

Pacific Biosciences' Gross Profit is increasing over the years with slightly volatile fluctuation. Gross Profit is expected to dwindle to about 28.8 M. Gross Profit is the profit Pacific Biosciences of makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2008-12-31

Previous Quarter

10 M

Current Value

10.1 M

Quarterly Volatility

5.8 M

Credit Downgrade

Yuan Drop

Covid

Check Pacific Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacific Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 56 M, Interest Expense of 14.1 M or Total Revenue of 79 M, as well as many indicators such as Price To Sales Ratio of 3.1, Dividend Yield of 0.0 or PTB Ratio of 0.94. Pacific financial statements analysis is a perfect complement when working with Pacific Biosciences Valuation or Volatility modules.

Check out the analysis of Pacific Biosciences Correlation against competitors.

Latest Pacific Biosciences' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Pacific Biosciences of over the last few years. Gross profit is a required income statement account that reflects total revenue of Pacific Biosciences of minus its cost of goods sold. It is profit before Pacific Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Pacific Biosciences' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacific Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 47.67 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Pacific Gross Profit Regression Statistics

	Arithmetic Mean	31,075,838
	Geometric Mean	21,066,496
	Coefficient Of Variation	59.22
	Mean Deviation	14,710,683
	Median	34,576,000
	Standard Deviation	18,404,059
	Sample Variance	338.7T
	Range	57.9M
	R-Value	0.67
	Mean Square Error	197.6T
	R-Squared	0.46
	Significance	0
	Slope	2,608,684
	Total Sum of Squares	5080.6T

Pacific Gross Profit History

	2025	28.8 M
	2024	37.3 M
	2023	52.8 M
	2022	49 M
	2021	58.9 M
	2020	32.6 M
	2019	34.6 M

Other Fundumenentals of Pacific Biosciences

Gross Profit Margin

Pacific Biosciences Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment	Long Term Debt	Net Receivables	Common Stock	Net Tangible Assets	Long Term Debt Total	Deferred Long Term Liab	Capital Surpluse	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.8	0.91	-0.77	0.77	0.95	0.99	0.95	0.37	0.9	0.89	0.8	-0.27	-0.78	0.78	0.23	0.88	-0.88	0.91	0.97	0.87
Total Stockholder Equity	0.97		0.76	0.84	-0.79	0.75	0.95	0.91	0.93	0.32	0.89	0.92	0.84	-0.25	-0.69	0.8	0.24	0.87	-0.9	0.9	0.95	0.87
Current Deferred Revenue	0.8	0.76		0.62	-0.47	0.45	0.83	0.8	0.87	0.39	0.59	0.69	0.52	-0.22	-0.55	0.54	0.3	0.68	-0.6	0.59	0.87	0.53
Net Debt	0.91	0.84	0.62		-0.85	0.89	0.77	0.92	0.76	0.38	0.93	0.71	0.75	-0.22	-0.95	0.71	0.23	0.8	-0.76	0.91	0.8	0.88
Retained Earnings	-0.77	-0.79	-0.47	-0.85		-0.93	-0.64	-0.73	-0.59	-0.48	-0.93	-0.75	-0.82	0.31	0.82	-0.84	-0.37	-0.82	0.8	-0.83	-0.65	-0.9
Accounts Payable	0.77	0.75	0.45	0.89	-0.93		0.6	0.75	0.57	0.52	0.93	0.63	0.79	-0.44	-0.87	0.74	0.21	0.76	-0.69	0.79	0.64	0.84
Short Term Investments	0.95	0.95	0.83	0.77	-0.64	0.6		0.92	0.99	0.32	0.78	0.9	0.8	-0.23	-0.6	0.71	0.27	0.89	-0.85	0.87	0.97	0.8
Total Liab	0.99	0.91	0.8	0.92	-0.73	0.75	0.92		0.93	0.39	0.88	0.84	0.75	-0.27	-0.81	0.74	0.22	0.86	-0.83	0.89	0.95	0.84
Total Current Assets	0.95	0.93	0.87	0.76	-0.59	0.57	0.99	0.93		0.34	0.76	0.87	0.75	-0.24	-0.59	0.68	0.22	0.86	-0.81	0.82	0.99	0.74
Short Term Debt	0.37	0.32	0.39	0.38	-0.48	0.52	0.32	0.39	0.34		0.4	0.37	0.51	-0.48	-0.43	0.55	0.24	0.5	-0.26	0.31	0.35	0.32
Property Plant Equipment	0.9	0.89	0.59	0.93	-0.93	0.93	0.78	0.88	0.76	0.4		0.8	0.81	-0.32	-0.84	0.83	0.27	0.86	-0.85	0.87	0.81	0.91
Long Term Debt	0.89	0.92	0.69	0.71	-0.75	0.63	0.9	0.84	0.87	0.37	0.8		0.8	-0.29	-0.55	0.86	0.27	0.86	-0.96	0.85	0.9	0.85
Net Receivables	0.8	0.84	0.52	0.75	-0.82	0.79	0.8	0.75	0.75	0.51	0.81	0.8		-0.39	-0.65	0.79	0.29	0.91	-0.77	0.9	0.74	0.85
Common Stock	-0.27	-0.25	-0.22	-0.22	0.31	-0.44	-0.23	-0.27	-0.24	-0.48	-0.32	-0.29	-0.39		0.14	-0.33	0.13	-0.35	0.24	-0.25	-0.25	-0.27
Net Tangible Assets	-0.78	-0.69	-0.55	-0.95	0.82	-0.87	-0.6	-0.81	-0.59	-0.43	-0.84	-0.55	-0.65	0.14		-0.6	-0.28	-0.69	0.61	-0.8	-0.63	-0.79
Long Term Debt Total	0.78	0.8	0.54	0.71	-0.84	0.74	0.71	0.74	0.68	0.55	0.83	0.86	0.79	-0.33	-0.6		0.31	0.82	-0.86	0.75	0.73	0.83
Deferred Long Term Liab	0.23	0.24	0.3	0.23	-0.37	0.21	0.27	0.22	0.22	0.24	0.27	0.27	0.29	0.13	-0.28	0.31		0.32	-0.31	0.25	0.23	0.27
Capital Surpluse	0.88	0.87	0.68	0.8	-0.82	0.76	0.89	0.86	0.86	0.5	0.86	0.86	0.91	-0.35	-0.69	0.82	0.32		-0.83	0.9	0.85	0.9
Short Long Term Debt	-0.88	-0.9	-0.6	-0.76	0.8	-0.69	-0.85	-0.83	-0.81	-0.26	-0.85	-0.96	-0.77	0.24	0.61	-0.86	-0.31	-0.83		-0.86	-0.85	-0.91
Net Invested Capital	0.91	0.9	0.59	0.91	-0.83	0.79	0.87	0.89	0.82	0.31	0.87	0.85	0.9	-0.25	-0.8	0.75	0.25	0.9	-0.86		0.83	0.95
Net Working Capital	0.97	0.95	0.87	0.8	-0.65	0.64	0.97	0.95	0.99	0.35	0.81	0.9	0.74	-0.25	-0.63	0.73	0.23	0.85	-0.85	0.83		0.77
Capital Stock	0.87	0.87	0.53	0.88	-0.9	0.84	0.8	0.84	0.74	0.32	0.91	0.85	0.85	-0.27	-0.79	0.83	0.27	0.9	-0.91	0.95	0.77

Click cells to compare fundamentals

About Pacific Biosciences Financial Statements

Pacific Biosciences stakeholders use historical fundamental indicators, such as Pacific Biosciences' Gross Profit, to determine how well the company is positioned to perform in the future. Although Pacific Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pacific Biosciences' assets and liabilities are reflected in the revenues and expenses on Pacific Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pacific Biosciences of. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	37.3 M	28.8 M
Gross Profit Margin	0.24	0.28

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:

How To Invest In Pacific

Details

Is Pacific Stock a good investment?

Details

What is Pacific Biosciences' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Pacific Biosciences Correlation against competitors.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.59)

Revenue Per Share

0.561

Quarterly Revenue Growth

(0.33)

Return On Assets

(0.12)

Return On Equity

(0.51)

The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pacific Gross Profit from 2010 to 2025

Latest Pacific Biosciences' Gross Profit Growth Pattern

Pacific Gross Profit Regression Statistics

Pacific Gross Profit History

Other Fundumenentals of Pacific Biosciences

Pacific Biosciences Gross Profit component correlations

About Pacific Biosciences Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY